Fed. Circ. To Eye Gene Patent Ruling's Reach In Myriad Case
The Federal Circuit will hear arguments Monday in a case that may clarify whether the U.S. Supreme Court's decision that Myriad Genetics Inc. cannot patent human genes invalidates other inventions involving...To view the full article, register now.
Already a subscriber? Click here to view full article